Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor α in advanced cancer patients

被引:0
作者
Zubelewicz, B [1 ]
Romanowski, W [1 ]
Braczkowska, B [1 ]
Lissoni, P [1 ]
Braczkowski, R [1 ]
机构
[1] Silesian Univ, Sch Med, Dept Internal Med 5, PL-41902 Bytom, Poland
关键词
advanced cancer; interleukin-6; tumor necrosis factor alpha;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor Necrosis Factor alpha administered in the therapy of advanced cancer influences certain hormones and cytokines secretion. In turn, these also modulate the biological activity of Tumor Necrosis Factor alpha. It has been shown in several studies that the cytokine Interleukin -6 (IL)-6 is produced in response to various hormones and other citokines eg. Tumor Necrosis Factor (TNF alpha). In our study we focused on the Interleukin-6 (IL-6) secretion in response to TNF alpha administration in 12 patients undergoing TNF alpha biotherapy due to advanced neoplastic disease. Plasma IL-6 was estimated prior and at various time points (2, 3, 5 a,d 12 hours) after TNF alpha intravenous infusion. IL-6 level was estimated with ELISA method. In conclusion, we suggest the stimulating influence of hrec TNF alpha administered as therapy for advanced cancer on IL-6 secretion.
引用
收藏
页码:449 / 452
页数:4
相关论文
共 50 条
[21]   Relationship between serum levels of interleukin-6, tumor necrosis factor-α and bone turnover markers in prostate cancer patients [J].
Akimoto, S ;
Okumura, A ;
Fuse, H .
ENDOCRINE JOURNAL, 1998, 45 (02) :183-189
[22]   The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome [J].
Liu H. ;
Liu J. ;
Xiong S. ;
Shen G. ;
Zhang Z. ;
Xu Y. .
Current Medical Science, 2000, 20 (3) :200-202
[23]   Tumor necrosis factor-α and interleukin-6 in cirrhotic patients with spontaneous bacterial peritonitis [J].
Muhammed AM Suliman ;
Fawzy MH Khalil ;
Salam SA Alkindi ;
Anil V Pathare ;
Ali AA Almadhani ;
Neveen AAI Soliman .
World Journal of Gastrointestinal Pathophysiology, 2012, (05) :92-98
[24]   Distinct activation of tumor necrosis factor-α and interleukin-6 in the spinal cord after surgical incision in rats [J].
Zhang, Yan-Ling ;
Xu, Jun-Mei ;
Zhou, Pei ;
Zhong, Xiao-Lin ;
Dai, Ru-Ping .
MOLECULAR MEDICINE REPORTS, 2012, 5 (06) :1423-1427
[25]   Tumor necrosis factor-α, interleukin-1β and interleukin-6 in the cerebrospinal fluid of newborn with meningitis [J].
Krebs, VLJ ;
Okay, TS ;
Okay, Y ;
Vaz, FAC .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (01) :7-13
[26]   TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-6 IN CRITICAL ILLNESS POLYNEUROMYOPATHY [J].
VERHEUL, GAM ;
DEJONGHLEUVENINK, J ;
DECOUL, AAWO ;
VANLANDEGHEM, AAJ ;
VANPUYENBROEK, MJE .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1994, 96 (04) :300-304
[27]   Impact of carotid artery stenting on plasma interleukin-6, tumor necrosis factor-α and C-reactive protein [J].
Xia, Z. -Y. ;
Yang, H. ;
Qu, Huai-Qian ;
Cheng, W. -D. ;
Wang, L. -X. .
INTERNATIONAL ANGIOLOGY, 2012, 31 (01) :28-32
[28]   Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-α and interleukin-6 in patients with sepsis [J].
Oberhoffer, M ;
Karzai, W ;
Meier-Hellmann, A ;
Bögel, D ;
Fassbinder, J ;
Reinhart, K .
CRITICAL CARE MEDICINE, 1999, 27 (09) :1814-1818
[29]   Interleukin-6 and tumor necrosis factor-α levels in chronic lymphocytic leukemia: correlation with patients' characteristics and outcome [J].
Al-Adl, Menna ;
Elwasefy, Shereen Ahmed ;
Youssef, Magdy M. ;
El-Said, Afaf ;
Refaat, Sherif ;
EL-Sebaie, Ahmed ;
Badawy, Heba K. .
EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (04) :368-377
[30]   PLASMA-LEVELS AND IN-VITRO PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH AMEBIC LIVER-ABSCESS [J].
GONZALEZAMARO, R ;
ANDRADE, S ;
BARANDA, L ;
ABUDMENDOZA, C ;
PORTALES, DP ;
MONCADA, B ;
LLORENTE, L .
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1994, 46 (03) :209-213